Next Sequence
Avsnitt

TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery

Next Sequence
Dela

Cortex Discovery’s in silico drug discovery platform is based on its leading-edge AI technology which can predict molecule properties in all therapeutic fields. The accuracy of its predictions has been validated in the lab, and rivals that of experiments.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Loretta TIOIELA. Innehållet i podden är skapat av Loretta TIOIELA och inte av, eller tillsammans med, Poddtoppen.